Weiss Multi Strategy Advisers LLC Vanda Pharmaceuticals Inc. Transaction History

Weiss Multi Strategy Advisers LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $150,000 - $336,000	-20,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $371,400 - $524,099	-30,000 Reduced 60.0%	20,000 $328,000
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $368,100 - $473,700	-30,000 Reduced 37.5%	50,000 $664,000
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $66,850 - $94,250	-5,000 Reduced 5.88%	80,000 $1.13 Million
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $158,310 - $279,450	9,000 Added 11.84%	85,000 $1.56 Million
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $682,920 - $1.13 Million	36,000 Added 90.0%	76,000 $1.99 Million
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $11,716 - $14,766	642 Added 1.63%	40,000 $918,000
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $8,955 - $12,294	-642 Reduced 1.6%	39,358 $750,000
Q1 2018 May 15, 2018	SELL	$14.05 - $20.2 $140,500 - $202,000	-10,000 Reduced 20.0%	40,000 $674,000
Q4 2017 Feb 14, 2018	SELL	$12.85 - $18.1 $64,250 - $90,500	-5,000 Reduced 9.09%	50,000 $760,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $847,000 - $1.04 Million	55,000	55,000 $985,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $288M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.